FDA-cleared profile

Chest-CAD

Imagen Technologies, Inc · X-ray/Radiography · FDA-cleared (510(k))

Authorized purpose: Concurrent CADe reading aid that identifies, categorizes, and highlights suspicious regions of interest on adult chest radiographs

Clinical role
Concurrent reading aid for physician interpretation, with overlay toggled in the PACS viewer; not a replacement for physician interpretation
Images and patients
X-ray/Radiography · Chest/thorax, with ROI categories covering cardiac, mediastinum/hila, lungs, pleura, bones, soft tissues, hardware, and other
Key limitation
Keep in mind: Indicated for adults only and intended as an assistive concurrent read; suspicious categories are broad ROIs rather than a single disease diagnosis, and physician interpretation remains necessary

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: Concurrent CADe reading aid that identifies, categorizes, and highlights suspicious regions of interest on adult chest radiographs
  • Which images or clinical context are in scope?Modality: X-ray/Radiography Anatomy or clinical context: Chest/thorax, with ROI categories covering cardiac, mediastinum/hila, lungs, pleura, bones, soft tissues, hardware, and other Input: Adult digital chest radiograph studies received from a DICOM node
  • Who uses it?Intended users: Physicians
  • What does the software produce?Output: DICOM Presentation State overlay for each image with ROI category text and bounding boxes when suspicious ROIs are detected, or No ROI(s) Detected with no boxes; overlay can be toggled in the PACS viewer
  • What is its most important limitation?Key limitation: Indicated for adults only and intended as an assistive concurrent read; suspicious categories are broad ROIs rather than a single disease diagnosis, and physician interpretation remains necessary

Clinical takeaway. Clinical role: Concurrent CADe reading aid that identifies, categorizes, and highlights suspicious regions of interest on adult chest radiographs

Evidence takeaway. Evidence from the reviewed source record: Standalone testing used 20,000 chest radiographs from 12 US hospitals, outpatient centers, and specialty centers: overall sensitivity 0.908 (95% CI 0.905-0.911), specificity 0.887 (0.885-0.889), and ROC AUC 0.976 (bootstrap CI 0.975-0.976). Category AUC ranged from 0.921 to 0.994. MRMC reader study used 24 readers and 238 cases from 9 US centers: reader AUC improved 0.836 to 0.894, sensitivity 0.757 to 0.856, and specificity 0.843 to 0.870 with Chest-CAD assistance

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
Concurrent CADe reading aid that identifies, categorizes, and highlights suspicious regions of interest on adult chest radiographs
  • Exact FDA submission
  • Checked 2026-09-08
Workflow role
Concurrent reading aid for physician interpretation, with overlay toggled in the PACS viewer; not a replacement for physician interpretation
  • Exact FDA submission
  • Checked 2026-09-08
Required input
Adult digital chest radiograph studies received from a DICOM node
  • Exact FDA submission
  • Checked 2026-09-08
Output and clinician action
DICOM Presentation State overlay for each image with ROI category text and bounding boxes when suspicious ROIs are detected, or No ROI(s) Detected with no boxes; overlay can be toggled in the PACS viewer
  • Exact FDA submission
  • Checked 2026-09-08
Care setting
Adult chest-radiograph interpretation workflow; FDA bench and reader studies included hospitals, outpatient centers, and specialty centers
  • Exact FDA submission
  • Checked 2026-09-08
Intended users
Physicians
  • Exact FDA submission
  • Checked 2026-09-08
Limitations
Indicated for adults only and intended as an assistive concurrent read; suspicious categories are broad ROIs rather than a single disease diagnosis, and physician interpretation remains necessary
  • Exact FDA submission
  • Checked 2026-09-08
Evidence summary
Standalone testing used 20,000 chest radiographs from 12 US hospitals, outpatient centers, and specialty centers: overall sensitivity 0.908 (95% CI 0.905-0.911), specificity 0.887 (0.885-0.889), and ROC AUC 0.976 (bootstrap CI 0.975-0.976). Category AUC ranged from 0.921 to 0.994. MRMC reader study used 24 readers and 238 cases from 9 US centers: reader AUC improved 0.836 to 0.894, sensitivity 0.757 to 0.856, and specificity 0.843 to 0.870 with Chest-CAD assistance
  • Exact FDA submission
  • Checked 2026-09-08

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
Standalone testing used 20,000 chest radiographs from 12 US hospitals, outpatient centers, and specialty centers: overall sensitivity 0.908 (95% CI 0.905-0.911), specificity 0.887 (0.885-0.889), and ROC AUC 0.976 (bootstrap CI 0.975-0.976). Category AUC ranged from 0.921 to 0.994. MRMC reader study used 24 readers and 238 cases from 9 US centers: reader AUC improved 0.836 to 0.894, sensitivity 0.757 to 0.856, and specificity 0.843 to 0.870 with Chest-CAD assistance
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Reported sensitivity
90.8% (95% CI: 90.5%, 91.1%)
  • Public source
  • Exact FDA submission
  • Checked 2026-09-01

Model sensitivity reported by ACR AI Central. Review endpoint, threshold, study population, and tested version before comparison.

Reported specificity
88.7% (95% CI: 88.5%, 88.9%)
  • Public source
  • Exact FDA submission
  • Checked 2026-09-01

Model specificity reported by ACR AI Central. Review endpoint, threshold, study population, and tested version before comparison.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

Chest-CAD regulatory performance study summary

  • DesignStand-alone performance and reader study (ACR AI Central category)
  • PopulationAdult
  • Scopeexact submission
  • Tested versionExact product version not reported; regulatory study summarized for FDA submission K210666
  • Samplen=20000
  • Sites12
  • IndependenceIndependence not established

K210666

ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K210666. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-08
Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not verified: Pricing information is recorded but not verified against a resolving source.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Adult digital chest radiograph studies received from a DICOM node

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-08 · FDA K210666: Chest-CAD

  2. Routing

    Source context, not route validation: FDA packet describes secure cloud-based processing and delivery from a DICOM node to a PACS viewer, where the presentation-state overlay can be toggled; exact current cloud configuration, interfaces, and versions are not otherwise established

    Scope: Exact FDA submission.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-08 · FDA K210666: Chest-CAD

  3. AI processing

    Source context, not route validation: The exact FDA package describes Chest-CAD's platform as secure cloud-based processing in the Proposed Device column of its technological comparison table. Current hosting, data flow, and commercial configuration require vendor confirmation.

    Scope: Exact FDA submission. Packet wording: "Proposed Device Predicate Platform Secure cloud-based processing" … "Table 1 provides a comparison of the Technological Characteristics of Chest-CAD to the predicate RapidScreen™ RS-2000.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-11-14 · FDA K210666: Chest-CAD

  4. Returned objects

    Source context, not route validation: DICOM Presentation State overlay for each image with ROI category text and bounding boxes when suspicious ROIs are detected, or No ROI(s) Detected with no boxes; overlay can be toggled in the PACS viewer

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-08 · FDA K210666: Chest-CAD

  5. Viewer/worklist/report

    Unresolved route: DICOM Presentation State overlay for each image with ROI category text and bounding boxes when suspicious ROIs are detected, or No ROI(s) Detected with no boxes; overlay can be toggled in the PACS viewer

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-08 · FDA K210666: Chest-CAD

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
The exact FDA package describes Chest-CAD's platform as secure cloud-based processing in the Proposed Device column of its technological comparison table. Current hosting, data flow, and commercial configuration require vendor confirmation.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "Proposed Device Predicate Platform Secure cloud-based processing" … "Table 1 provides a comparison of the Technological Characteristics of Chest-CAD to the predicate RapidScreen™ RS-2000.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

Integration
FDA packet describes secure cloud-based processing and delivery from a DICOM node to a PACS viewer, where the presentation-state overlay can be toggled; exact current cloud configuration, interfaces, and versions are not otherwise established
  • Exact FDA submission
  • Checked 2026-09-08
Security
Imagen's security policy (effective 2024-04-02) states HIPAA, HITRUST CSF and SOC 2 Type II compliance, encryption in transit and at rest, least-privilege access, multi-factor authentication, audit trails and incident response. Vendor statement; no report or certificate was read.
  • Vendor-wide
  • Checked 2026-10-26

Vendor statement, not an attestation. Identity bridge: the policy is on imagen.ai, whose AI software page lists this product by name, and the FDA letter for this entry names Imagen Technologies, Inc. (New York). The policy is company-wide; exact-release scope is not established. A 2023 HITRUST release names the Care Delivery Services platform, not the devices, and is not applied.

Input or output interoperability

DICOM is explicitly referenced in the described input, output, or workflow.

exact submission · checked 2026-09-01

The model card does not establish every supported DICOM object, transfer method, or local interface.

ACR exact-submission catalog context

ACR AI Central provides an exact-submission model card for Chest-CAD; FDA labeling remains controlling for clinical use, limitations, and performance.

exact submission · checked 2026-09-08
Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K210666
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
X-ray/Radiography
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Anatomy
Chest/thorax, with ROI categories covering cardiac, mediastinum/hila, lungs, pleura, bones, soft tissues, hardware, and other
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2021-07-20
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Exact FDA record reviewedStatus
2026-09-20Last searched
24Fields reviewed
9Source classes checked
1Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads

The refreshed discovery snapshot contains 1 PubMed and 0 ClinicalTrials.gov candidate record. Discovery metadata alone does not establish exact tested-product, version, population, and endpoint applicability, so all candidates remain quarantined and none was promoted. The current discovery snapshot contains 1 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, acr ai central product, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not verified - checked 2026-09-08 - Exact FDA submission

    No public price or quote for the exact K210666 configuration was established in this review.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-09-08 - Exact FDA submission

    No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Installation timeline: Not yet reviewed
  • Training: Not verified - checked 2026-09-08 - Exact FDA submission

    Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.

  • Monitoring: Not verified - checked 2026-09-08 - Exact FDA submission

    Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.

8 sources - 3 history items

Source ledger

  1. FDA K210666: Chest-CAD

    U.S. Food and Drug Administration - Published 2021-07-20 - Accessed 2026-09-08

    Scope: identity, clinicalUse, modality, anatomy, workflow, evidence, implementation, deployment

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. Chest-CAD model card (K210666)

    American College of Radiology - Published 2026-08-17 - Accessed 2026-09-01

    Scope: intendedUsers, careSetting, output, reportedSensitivity, reportedSpecificity, evidenceSummary, integration, anatomy, evidenceStudies, implementationCapabilities

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. openFDA exact recall query for K210666

    U.S. Food and Drug Administration - Accessed 2026-09-08

    Scope: postmarketSafety

  8. Imagen Security Policy

    Imagen Technologies - Published 2024-04-02 - Accessed 2026-10-26

    Scope: security

Research history

  1. K210666 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    fda record reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K251934

qXR-Detect

Qure.Ai Technologies

Authorized purpose: qXR-Detect is an adult chest-radiograph concurrent reading aid that identifies, highlights and categorizes suspicious regions of interest across lung, pleura, mediastinum/hila/heart, bone, hardware and other categories; trained clinicians remain responsible for primary interpretation.

Modality
X-ray/Radiography
Anatomy
Chest/Lung; pleura, mediastinum/hila/heart, bone, hardware and other chest-radiograph regions
Decision
2026-01-16
FDA-cleared K252953

Velmeni for Dentists (V4D) Endo-Perio

Velmeni, Inc.

Authorized purpose: Concurrent-read CADe to assist dentists in detecting specified tooth and jaw anatomy, bone-level landmarks, and root-canal-treated teeth in digital radiographs of permanent teeth in patients 15 years or older.

Modality
X-ray/Radiography
Anatomy
Permanent teeth and jaw/maxillofacial anatomy, including enamel, dentine, pulp, root, mental foramen, inferior alveolar canal, maxillary sinus, cementoenamel junction, crestal bone, and root-canal-treated teeth
Decision
2026-05-11
FDA-cleared K242437

Smile Dx®

Cube Click, Inc.

Authorized purpose: Aids dentists reviewing bitewing and periapical radiographs of permanent teeth by detecting/segmenting caries and periapical radiolucencies, identifying restorations and dental anatomy, and measuring mesial/distal bone levels; it does not replace dentist review.

Modality
X-ray/Radiography
Anatomy
Dental/Maxillofacial
Decision
2025-05-14
FDA-cleared K242171

TechCare Trauma

Milvue

Authorized purpose: Aids clinicians and radiologists reviewing 2D X-ray radiographs by detecting, localizing, and characterizing fractures across the FDA-listed appendicular, hip/pelvis, clavicle, and thorax/rib examinations, and by detecting elbow joint effusion on lateral elbow or forearm views in children/adolescents and adults; results are not standalone clinical decisions.

Modality
X-ray/Radiography
Anatomy
MSK
Decision
2025-01-17

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history